Osaka, Japan

Minako Mikamiyama



Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Minako Mikamiyama: Innovator in Antiviral Compounds

Introduction

Minako Mikamiyama is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of antiviral research, particularly in developing compounds that inhibit the influenza virus. With a total of four patents to her name, her work is recognized for its potential impact on public health.

Latest Patents

Mikamiyama's latest patents include the "Substituted polycyclic carbamolypyridone derivative" and the "Substituted polycyclic carbamoylpyridone derivative." Both inventions focus on providing compounds that exhibit antiviral activities, specifically targeting the influenza virus. These compounds are particularly noted for their cap-dependent endonuclease inhibitory activity, which is crucial in the fight against viral infections.

Career Highlights

Throughout her career, Minako Mikamiyama has been associated with Shionogi & Company Limited, where she has been able to apply her innovative ideas in a collaborative environment. Her work has not only advanced scientific understanding but also contributed to the development of practical solutions for viral infections.

Collaborations

Mikamiyama has worked alongside notable colleagues such as Toshiyuki Akiyama and Makoto Kawai. Their collaborative efforts have further enhanced the research and development of antiviral compounds, showcasing the importance of teamwork in scientific innovation.

Conclusion

Minako Mikamiyama stands out as a key figure in the field of antiviral research, with her inventions paving the way for new treatments against influenza. Her dedication to innovation and collaboration continues to inspire advancements in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…